NCT01376271View on ClinicalTrials.gov

Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

CompletedOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Social Phobia

Interventions

DRUG

Paroxetine

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01376271 - Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term) | Biotech Hunter | Biotech Hunter